#Recipharm

Scinai Immunotherapeutics Reports Remarkable Growth and Development in 2025 Financial Results Scinai Immunotherapeutics has showcased a significant leap in CDMO revenues and strategic collaborations in its latest financial results.

Scinai Immunotherapeutics Reports Remarkable Growth and Development in 2025 Financial Results #Israel #Jerusalem #Scinai #PC111 #Recipharm

Scinai Strengthens Robotic Aseptic Fill Finish Platform with Expanded IIA Support Scinai Immunotherapeutics has secured enhanced funding from the Israel Innovation Authority to advance its robotic aseptic fill finish platform, aimed at boosting biomanufacturing capabilities.

Scinai Strengthens Robotic Aseptic Fill Finish Platform with Expanded IIA Support #Scinai_Immunotherapeutics #Israel #Jerusalem #IIA #Recipharm

Big pharma firms have paused nearly £2bn in UK investments this year Government’s plans in disarray before Trump talks as MSD, Eli Lilly and AstraZeneca moves prompt job fears

#lifesciences #biotech #Pharmaceuticals #AstraZeneca #Trump #MSD #EliLilly #drugpricing #ABPI #BristolMyersSquibb #NHS #VPAG #Sanofi #Novartis #BioNTech #Moderna #Haleon #Indivior #VeronaPharma #AdaptimmuneTherapeutics #WorldMeds #GSK #RentschlerBiopharma #Recipharm
zurl.co/3FQOT